Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Diseases

Explore clinical trials studying Salivary Gland Diseases. Study availability and eligibility vary by location and protocol.

710 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Diseases trial results

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

NCT01621802

Conditions
Infections, Measles, Measles-Mumps-Rubella, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Benton, Arkansas, United States
View all 67 locations
View Trial Details
Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

NCT01702428

Conditions
Infections, Measles, Mononegavirales Infections, +14 more
Locations
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
View all 90 locations
View Trial Details
Completed

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

NCT00656513

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +21 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Hospital of Saint Raphael New Haven, Connecticut, United States
  • Emory Crawford Long Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Completed

Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma

NCT02393820

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
Locations
  • Institut de Cancérologie de l'Ouest Paul Papin Angers, France
  • CHU Bordeaux Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View all 15 locations
View Trial Details

Related conditions